Pharmacological effects of a new antiarthritic agent, IX 207-887.
Mackenzie
A R
AR
Sandoz Research Institute Berne Ltd, Berne, Switzerland.
Bollinger
P
P
Cooper
P H
PH
Del Pozo
E
E
Elford
P
P
Graeber
M
M
Gubler
H U
HU
Leutwiler
A
A
Payne
T
T
Ruch
W
W
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007375:Interleukin-1 / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013876:Thiophenes / Q000494:pharmacology* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D011453:Prostaglandins; D013876:Thiophenes; C061029:IX 207-887; D011451:Prostaglandin-Endoperoxide Synthases